title: [Own experiences (1989-1994) in the treatment of adolescent schizophrenic paranoid syndromes with Leponex produced by Sandoz company].
abstract: 31 patients with schizophrenic adolescent paranoid syndrome were treated by Leponex-Sandoz after the establishing of the therapeutic indications. We did not observe any considerable side effects. We observed the regression of positive symptoms at 19-day of the treatment and the regression of negative symptoms at 23-day of the therapy. We conclude that Leponex-Sandoz is effective and safe medication in the treatment of adolescent schizophrenic paranoid syndrome.
authors.affiliation: Oddziału Psychiatrii Wieku Rozwojowego Wojewódzkiego Szpitala Neuropsychiatrii w Lublińcu.
authors.forename: M
authors.initials: M
authors.lastname: Abczyńska
authors.forename: Z
authors.initials: Z
authors.lastname: Kaźmirek
authors.forename: J
authors.initials: J
authors.lastname: Syguda
authors.forename: K
authors.initials: K
authors.lastname: Termińska
mesh_terms: D000293:Adolescent; D003024:Clozapine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D000297:Psychology, Adolescent; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D003024:Clozapine
vernacular_title: Własne piecioletnie doświadczenia (1989-1994) w leczeniu młodziezowych, schizofrenicznych zespołów paranoidalnych Leponexem firmy Sandoz.